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ABSTRACT 
 
Pyruvate kinase (PK), the tenth enzyme in glycolysis, undergoes significant activity 
changes with thiol modification at cysteine residues. This research explored the extent of these 
activity changes and of cysteine labeling experienced by PK after direct thiol modification by 
hydrogen peroxide, Ellman’s reagent, hypochlorous acid, glutathione, and dansyl-labeled 
glutathione derivatives. Mixed reactions with thiol-modifying agents and the reducing agents 
dithiothreitol and tris(2-carboxyethyl)phosphine examined the reversibility of labeling and 
restoration of activity. Results of these studies confirmed that PK activity may be modulated by 
cellular redox conditions. They determined that some of the residues responsible for labeling 
were not involved in PK functionality and that different reagents had varying degrees of 
modifying power and selectivity for functionally-relevant or non-functionally-relevant cysteine 
residues. They also indicated that full in vitro activity and observable thiol reduction occurred in 
slightly oxidizing conditions. This implied that PK could “protect” itself against functionally-
relevant thiol modification at low physiological oxidant concentrations, potentially through non-
functionally-relevant cysteine residues and other amino acids, and structurally reorient itself at 
these concentrations for effective function. This may suggest other protective roles for PK as a 
buffer against oxidation of more sensitive cysteine-containing proteins, such as tubulin and 
GAPDH, or as a marker for high levels of cellular oxidative stress. 
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PART I: INTRODUCTION  
A. The Importance of Cellular Structure 
Perhaps the most essential principle in biology and biochemistry is that structure begets 
function. At every organizational level—from atoms to organs—the ability of some organismal 
component to take on its proper role within a larger system is largely contingent upon its size, 
shape, charge, and other structural features. As a general example, the specific function of an 
enzyme is determined by its primary, secondary, tertiary, and quaternary structures. The enzyme 
may be divided into individual polypeptide subunits that can then be unfolded into strings of 
amino acids interacting with one another and the surrounding environment. These structures 
constitute active sites particular to the set of substrates upon which the enzyme operates and 
binding sites for allosteric regulators. Altering these amino acid and polypeptide constructs—
either through deleterious mutation or denaturation by an increase in temperature, added 
denaturing agent, a prion, etc.—destroys protein structure and almost always renders it incapable 
of performing its designated task. The impact of protein structure on functionality is illustrated in 
sickle cell anemia, in which altering a single amino acid residue in hemoglobin drastically 
modifies the protein’s conformation and reduces erythrocyte efficiency in oxygen transport.1 
Consequently, the impact of structure on function is the focus of many biochemical studies and 
will be the major topic of discussion in this thesis. 
B. An Introduction to the Cytoskeleton and Microtubules 
At the cellular level, structure can be described by the paradoxical phrase of “dynamic 
stability.” It must be stable and resilient enough to hold its shape in the face of environmental 
stresses, yet flexible to accommodate internal needs. Cell structure is maintained through an 
enormous, interwoven network of three major types of fibrous protein filaments: actin-based 
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microfilaments, variable intermediate filaments (of which there are 60 or more types in the 
human body), and microtubules (MTs). The discussion here focuses primarily on this third 
category. As their name suggests, MTs are hollow, tubular protein fibers located throughout the 
cytoplasm and along the inner face of the plasma membrane, where they maintain cellular 
integrity, provide scaffolding for arranging multi-protein complexes, and serve as highways for 
vesicular and protein transport by motor proteins like kinesin and dynein. MTs are also found in 
the nucleus, where they compose centrosome spindle fibers that split daughter chromosomes 
during the meta- and anaphases of mitosis and meiosis.2 As such, they play vital roles in cellular 
viability, performance, growth, and replication. 
 
 
 
 
 
 
Figure 1: Electron Micrograph of Microtubules in Bovine Cells3 
 
A single MT comprises thirteen protofilaments that assemble and disassemble in a 
directional manner with the help of GTP hydrolysis. These protofilaments are long, thin fibers 
composed of polar heterodimers of α-tubulin and β-tubulin arranged in a repeated pattern. 
(Another third form, γ-tubulin, is typically found in nuclear centrosomal MTs. As the primary 
focus of this paper pertains more to MTs in the cytoplasm, γ-tubulin will be of less relevance to 
the discussion.1) Tubulin heterodimers are acidic; various yeast tubulin forms have isoelectric 
points between 4.3 and 4.9. As a result, MTs surfaces are highly anionic in character.4 
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C. Microtubules in the Context of Glycolytic Enzyme Electrostatics 
Tubulin’s high anionic density allows MTs to play integral roles in localizing and 
organizing more basic and cationic metals, peptides, enzymes, and multi-enzyme complexes. 
The electrostatic interactions that exist between these macromolecules and ions have been 
studied extensively over the past few decades, and it has been hypothesized that they contribute 
to the regulation of many multi-enzyme mechanisms. 5 The most notable of these associated 
enzymes, and possibly the ones most extensively studied in recent years, are the ten required for 
glycolysis, the major catabolic process by which glucose is converted to pyruvate, two molecules 
of energy-rich adenosine triphosphate (ATP), and the reduced electron carrier nicotinamide 
adenine dinucleotide (NADH). 
It is logical to think that glycolytic enzymes would organize themselves along MTs 
through charge interactions. Glycolytic efficiency should theoretically increase with increasing 
proximity of enzymes catalyzing consecutive steps, as glycolytic intermediates could be rapidly 
shuttled down the assembly line.5 However, despite this logic, determining which glycolytic 
enzymes associate with MTs and to what extent they associate has been difficult. 
Figure 2: Diagram of Microtubule Structure3 
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In a study conducted by Walsh, Keith, and Knull, glycolytic enzyme associations with 
MTs were tested through a direct, in vitro method.6 Tubulin and individual enzymes were mixed 
in solutions of varying concentrations of 7% polyethylene glycol, which was used to reduce bulk 
water content and increase effective protein concentration within the system, thereby replicating 
cytosolic protein density. Upon centrifugation, co-pelleting between tubulin and enzymes was 
identified and quantified under the assumption that it occurred as a direct result of protein 
electrostatics. Co-pelleting was observed in high quantities with or without polyethylene glycol 
for four of the enzymes tested: glyceraldehyde-3-phosphate dehydrogenase (GAPDH), lactate 
dehydrogenase type-M, aldolase, and pyruvate kinase (PK). Two enzymes were found to co-
pellet only in the presence of polyethylene glycol, and still others, like enolase, did not co-pellet 
at all. Using fluorescence anisotropy, dissociation constant values were calculated for each 
enzyme at varying polyethylene glycol concentrations. Most glycolytic enzymes favored tubulin 
association in the presence of polyethylene glycol, indicating that they would favor similar 
association in high-protein cellular conditions. Notable was the fact that GAPDH and PK 
dissociation constant values fell in the micromolar range (between 1 and 4 µM), which 
corresponded to their typical cytosolic enzyme concentrations. This suggested that the two 
enzymes are bound to tubulin and MTs in vivo.6 
To investigate the nature of these intermolecular interactions, increasing concentrations 
of potassium chloride were added to enzyme-tubulin-polyethylene glycol systems to enhance 
their ionic strengths. If the enzymes indeed associated electrostatically with tubulin, the 
participating proteins would be charged along their surfaces. The addition of salt would 
effectively neutralize these charges, causing the proteins to lose affinity for and associate less 
with their oppositely-charged counterparts. If the interactions were not charged-based, one would 
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expect no change in association. GAPDH and PK association with tubulin generally decreased 
with increasing salt concentration. Consequently, it was concluded that these enzyme-tubulin 
interactions were at least partially electrostatic.6 These results were supported by later findings 
suggesting that at least 40% of GAPDH molecules in skeletal muscle are found bound to MTs 
and that PK regulates MT structure and (de)polymerization based on cellular metabolic state and 
levels of its primary substrate, phosphoenolpyruvate (PEP).7,8 (This regulation may also 
contribute to one PK isoform's role in cancer and tumor proliferation in neural tissue.9) 
This study’s results also suggested that other enzymes like enolase and hexokinase did 
not significantly interact with tubulin, yet this claim has been contested through other co-
pelleting experiments and investigation of these interactions in vivo.6  For example, p52, a form 
of α-enolase, was found to co-pellet with tubulin in bovine brain and testis cells; other enolase 
forms were found to associate with tubulin in Petrolisthes cinctipes claw muscle and in sperm 
tails of mature spermatozoa.2,10 Some findings have suggested that hexokinase binds and co-
pellets at least partially with tubulin, while others found it to associate more readily with 
mitochondria, where it is linked to oxidative phosphorylation.11,12 Thus, it is still unclear if other 
enzymes strongly interact with MTs through electrostatics, but primary data show that some, like 
GAPDH and PK, do so to a substantial degree. 
D. Connecting Oxidation and Disulfide Bonding 
MTs consist primarily of the isoforms α- and β-tubulin, both of which are rich in the 
amino acid cysteine (Cys). The cysteine side chain is a mercaptomethyl, or a methylene group 
with a thiol (-CH2SH). Modifying this thiol produces a highly reactive sulfur atom that can 
disulfide exchange with other sulfhydryls to stabilize itself. 
Cysteine Thiols in Pyruvate Kinase Activity 6 
 
 
 
The most abundant form of human heterodimeric tubulin (1TUB) contains twenty 
cysteine residues: α-tubulin contains twelve per unit, while β-tubulin has eight.13 
 
 
 
 
 
 
This abundance of thiols provides ample opportunity for disulfide bond exchange 
between tubulin sulfhydryls in the presence of thiol-modifying agents. Disulfide bonds are 
covalent and, while reversible, are much stronger than ionic and van der Waals interactions. 
Under normal conditions, they promote rigidity rather than permit structural dynamism. While 
this may stabilize active or regulatory site structures in certain proteins, not all disulfide bonds 
are necessary. For example, tubulin's cysteine residues are naturally reduced. No disulfide bonds 
are required to maintain its structure; in fact, they are harmful to it. The addition of thiol-
modifying agents causes tubulin to depolymerize, condense, and agglutinate with itself and other 
proteins.14,15 Should this happen in vivo, it could potentially wreak havoc on MT structure. 
E. The Neurological Significance of Microtubule Oxidation 
Considering that MTs play key roles in many cellular processes, it is impossible to 
imagine all of the possible consequences of drastic MT structural changes and loss of function. 
However, it is clear that none of these consequences would be beneficial for a cell. This is 
especially true for nerve cells that transduce signals down long, thin axons to other neurons, 
muscle fibers, and more. MT defects have been shown to damage the central and peripheral 
nervous systems and functionality of motor neurons.16 They have been implicated as a major 
Figure 3: X-ray Crystal Structure of 1TUB Dimer Complexed with GDP, GTP, and Taxotere13 
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contributing factor to neurodegenerative diseases including, but not limited to, distal hereditary 
motor neuropathy, frontotemporal dementia (FTD) and other tauopathies, amyotrophic lateral 
sclerosis (ALS), Charcot-Marie-Tooth disease (CMT, also known as hereditary motor sensory 
neuropathy), Alzheimer's disease, and forms of ataxia, paraplegia, and frontal lobe 
degeneration.16 Many of these issues arise from defects in post-translational modification of 
tubulin monomers, errors in tubulin folding, and dysfunctional interactions between MTs and 
MT-associated proteins. Consequently, one may assume that any drastic post-translational 
tubulin structural change—for example, through thiol modification and subsequent radical 
formation or disulfide exchange—could dramatically impact neuronal function and ultimately 
cause neurodegeneration.16 
F. Linking Electrostatics and Oxidative Damage—GAPDH and Tubulin 
Tubulin, with its reactive sulfhydryls, interacts with many cysteine-rich peptides and 
proteins. Given ample evidence of tubulin interactions with positively-charged, cysteine-
containing glycolytic enzymes, the influence of electrostatics on tubulin thiol modification must 
be considered. Tubulin oxidation through association with GAPDH has been studied extensively 
in the laboratory of Dr. Lisa Landino. 
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Through in vitro experiments with rabbit muscle GAPDH and mammalian brain tubulin, 
disulfide exchange in combined protein systems with added hydrogen peroxide was shown to be 
greater than exchange in isolated oxidized GAPDH or tubulin systems. It was thus concluded 
that disulfide exchange occurs between GAPDH and tubulin and enhances oxidative stress 
experienced by each protein.15 These findings were corroborated by other groups citing oxidative 
stress and agglutination of disulfide-bonded GAPDH as major factors in neuronal cell death.17 
They also coincided with research demonstrating GAPDH's ability to associate and dissociate 
with tubulin and induce MT bundling.18 
Landino and coworkers also found that disulfide exchange between tubulin and GAPDH 
decreased with increasing salt concentration, implicating electrostatics in at least partially 
contributing to enhanced disulfide exchange.15 This makes sense considering that holding the 
proteins closer together would increase the likelihood of interaction between their cysteine 
GAPDH Tubulin 
+ 
+ 
+ 
+ 
- 
- 
- 
- 
SH HS 
ROS 
GAPDH Tubulin 
+ 
+ 
+ 
+ 
- 
- 
- 
- 
S S 
SH SH 
SH SH 
GAPDH Tubulin 
+ 
+ 
+ 
- 
- 
- 
- 
S HS S SH 
GAPDH Tubulin 
+ 
+ 
+ 
+ 
- 
- 
- 
- 
SH S SH 
S ROS 
ROS 
Figure 4: Mechanism for GAPDH-Tubulin Disulfide Exchange 
Charge interactions between GAPDH and tubulin allow the two proteins to associate. With added intracellular radical 
oxygen species (ROS) or other thiol-modifying agents, sulfhydryls in both proteins are altered and can undergo intra-
protein or inter-protein disulfide exchange. 
+ 
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residues, and it would line up well with the results of Walsh and coworkers described 
previously.6 
G. Exploring the Potential Role of Pyruvate Kinase in Tubulin Oxidation 
The results of Landino's research warrant the question: do other cysteine-containing 
glycolytic enzymes interact similarly with tubulin? If so, identifying them and determining their 
influence on disulfide exchange would be prudent for researchers trying to further understand the 
structural and metabolic consequences of oxidative stress. Based on previous observations, the 
next best candidate for study is pyruvate kinase (PK), as it interacts significantly with tubulin in 
conditions reasonably representative of cellular conditions. 
PK catalyzes the final step of glycolysis, the dephosphorylation of PEP to pyruvate. The 
transferase falls into the beta-barrel protein family and is typically found as a homotetramer in 
the cytosol.19 Different isoforms in various species have isoelectric points ranging from 6.9 to 
8.0.4,20,21 (The rabbit PK used in this study had a pI of 7.6.22) Each monomer contains about 540-
560 residues, has a formula weight of 54-60 kDa, and can be divided into A, B, and C domains 
and a 42-amino acid-long amino-terminal region. The active site is found in a pocket between the 
A and B domains, while the enzyme is allosterically regulated at a binding site in the A and C 
domains.9 There are four PK isoenzymes: PKR, PKL, and PKM1 and PKM2. The first two are 
most prevalent in erythrocytes (R) and liver cells (L), respectively, and thus will be less relevant 
to this research. PKM1, found primarily in skeletal muscle, also predominates in brain and neural 
tissue. PKM2 is typically found in kidney, adipose, and lung tissue as well as in embryonic and 
neural tissues. 9 
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PK contains a sizable number of reduced cysteine residues under normal cellular 
conditions—in humans PKM1 and PKM2 contain nine and ten, respectively—suggesting that the 
enzyme could easily experience and contribute to oxidative stress.20,21 One of these residues, 
Cys358, has been shown to contribute significantly to PKM2 activity; its oxidation shuts down 
enzymatic function and assists in cellular antioxidant response to oxidative stress.23 Other studies 
have shown that exposure to the thiol-modifying agent 5,5-dithiobis-(2-nitrobenzoic acid) 
(Ellman’s reagent or DTNB) significantly reduces PK activity.24 Taken together with other 
investigations, it is reasonable to expect that, like GAPDH, PK could interact electrostatically 
with tubulin and enhance both proteins' stress from thiol disulfide exchange. This stress would 
not only disrupt MT structure, but also would reduce PK metabolic activity, thereby attacking 
cellular viability and performance in two major ways. In neural tissues, this could cause 
significant neurodegeneration and development of neurological disorders. 
H. Goals of this Research 
Much about the nature of PK response to thiol modification is unknown. Only a handful 
of reagents—primarily hydrogen peroxide and DTNB—have been tested with the enzyme.24,25 
Others found in the human body, such as hypochlorous acid and glutathione, have been studied 
Figure 5: X-ray Crystal Structure of PKM1 Complexed with Glycerol, K+, Mg2+, Pyruvate, and PO4-   20
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to a lesser extent. These agents may have different impacts on PK structure and activity based on 
their relative modifying strengths and targeting of residues. Further, while PK Cys358 is known 
to play a key role in maintaining functionality, its individual tendency towards oxidation, as well 
as those of other PK cysteine residues, is unknown. 
Consequently, the immediate goal of this thesis was to use kinetic assays and cysteine 
SDS-PAGE labeling procedures to expand upon previous studies and characterize PK oxidation 
by different reagents in vitro. This knowledge could eventually be placed in the context of 
combined PK-tubulin systems to compare oxidative stress in combined samples to stress 
experienced by the isolated proteins. The influence of electrostatics between tubulin and PK on 
thiol modification and disulfide exchange could eventually be analyzed using modified versions 
of published procedures. 
While the goals of this thesis were relatively narrow in scope, the results of this study 
enhanced a broader understanding of the consequences of thiol modification in the cell. It 
introduced possibilities for future courses of study, such as the impacts of cysteine modification 
on general catabolic function or the interactions of other enzymes or multi-enzyme complexes 
that co-locate with MTs and perhaps contribute to enhanced tubulin oxidation. Generalized even 
further, this project enhanced comprehension of factors contributing to metabolic dysfunction, 
structural degradation of neurons, and onset of neurodegenerative disease. This knowledge will 
ideally provide a foundation for developing concerted treatment measures aimed at limiting 
oxidative neuronal damage. With any luck, these treatments will make significant strides in the 
fight against what currently seem to be incurable illnesses. 
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PART II: MATERIALS AND METHODS 
A. Coupled Lactate Dehydrogenase Assays 
The kinetic portion of this research was used to determine the influence of redox state on 
enzymatic function in in vitro systems. This was done using a coupled lactate dehydrogenase 
(LDH) assay, the components and mechanism of which are shown in Figure 6.  
 
 
 
 
All reagents, including tetrameric LDH (product number L1254: MW = 140 kDa), were 
purchased from Sigma-Aldrich and resuspended in one of two buffers. These buffers, 50 mM 
phosphate buffer and 50 mM Tris buffer, were modified from buffers used in previous studies. 
They were prepared by diluting 0.1 M PB or Tris in an equal volume of deionized water 
(dIH2O). Buffer pH values fell around 7.4. To satisfy the reaction’s salt requirements and 
neutralize charge build-up, KCl and MgSO4 were added to each buffer to yield final 
concentrations of 100 mM KCl and 10 mM MgSO4, respectively. (These buffers are referenced 
as “SPB 7.4” and “STris 7.4.”) 
 Assay reagent concentrations are summarized in Table 1. STris 7.4 was used as the 
primary reaction buffer to permit use of reagents like TCEP that were unstable in phosphate 
buffer. PK (Sigma-Aldrich) was diluted to 1:100 of its original concentration in STris 7.4 (unless 
otherwise stated in SUPPLEMENTARY DATA, Appendix 2) to produce linear curves for easy 
comparison. [PK] varied between assays depending on the reaction volumes in which it was 
originally incubated. LDH, ADP, PEP, and NADH were added in excess. 
PEP 
ADP ATP 
Pyruvate Lactate 
NADH NAD
 +
 
PK LDH 
Figure 6: The Coupled LDH Assay  
NADH absor bs at 340 nm.  
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Reagent Volume in Well (µl) Assay Concentration 
STris 7.4 155-200 --- 
10 mM NADH in SPB 7.4 10 0.50 mM 
30 mM ADP in STris 7.4 10 1.5 mM 
30 mM PEP in SPB 7.4 5 0.75 mM 
1.43 x 10 -5 M LDH in STris 7.4 15 0.107 µM 
1:100 PK in STris 7.4 5 Varied with assay 
Table 1: Kinetic Assay Reagent Concentrations 
 
Final assay volumes were 200 µl and incubated at 25 ± 2 °C in clear 96-well microtiter 
plates. NADH absorbance at 340 nm was tracked spectrophotometrically with an ELX808 plate 
reader. Initial absorbances typically fell between 1.250 and 1.650 OD, though some began at 
higher or lower values depending on the speed with which the assay was prepared and placed in 
the plate reader. Eleven kinetic readings at 30-second intervals were performed over five 
minutes. Data was collected and processed using the KCjunior spectroscopic program. 
B. SDS-PAGE Analysis 
 
Specifics on this procedure may be found in SUPPLEMENTARY DATA, Appendix 3. 
C. Pyruvate Kinase Redox Reactions 
PKM1/PKM2 used in kinetic and SDS-PAGE analyses was purchased from Sigma-
Aldrich (product number P9136: tetramer MW = 237 kDa, monomer MW = 57 kDa) and 
suspended in 0.1 M phosphate buffer at pH 7.4 after purification with a desalting column; 
aliquots of 100-200 µl were stored at -80 ˚C. No sample was thawed and refrozen more than four 
times, though they were combined when necessary to minimize waste. Product contamination 
checks were performed by replacing LDH with STris 7.4 in the assay conditions described 
above. The negligible curves produced by these assays indicated that no LDH (or other NADH-
oxidizing reagent) contaminated the product. 
PK was reacted in initial volumes ranging from 15 to 22 µl. All reactions were incubated 
at 37 °C for 30 minutes (for single-step studies) or fifty minutes to one hour (for two-step 
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studies). Excess hydrogen peroxide (H2O2) was consumed with catalase (Sigma-Aldrich) 
prepared to 2 mg/ml in dIH2O; reactions with all other reagents were quenched by dilution to 
1:100 in STris 7.4 (unless otherwise stated in SUPPLEMENTARY DATA, Appendix 2). It was 
assumed that any remaining reagent molecules were spaced far enough away from PK after 
dilution to effectively stop further modification. 
Modifying agents included H2O2, hypochlorous acid (HOCl), Ellman's reagent (DTNB), 
dithiothreitol (DTT), and tris(2-carboxyethyl)phosphine (TCEP). Dilutions of H2O2 (store-
brand) and HOCl (Sigma-Aldrich) were prepared in dIH2O, while DTNB (Sigma-Aldrich) was 
prepared in SPB 7.4. DTT and TCEP (both Thermo Fisher Scientific) were prepared in SPB 7.4 
and STris 7.4, respectively. 
Reagents also included oxidized glutathione (GSSG, Sigma-Aldrich) and dansyl-labeled 
glutathione derivatives (DLGDs) produced by the Landino laboratory: a single-labeled oxidized 
form (D1), a double-labeled oxidized form (D2), and a single-labeled reduced form (DGSH). 
Oxidized DLGDs were prepared by reacting reduced glutathione (GSH, Sigma-Aldrich) with 
dansyl chloride (Sigma-Aldrich) and purifying it on a C8 column in washes of methanol (MeOH) 
+ dIH2O + 0.1% acetic acid (HAc). D1 eluted in 50% MeOH + 0.1% HAc, while D2 eluted in 
80% MeOH + 0.1% HAc. Elutions were dried under vacuum and stored at room temperature. 
DGSH was reduced from D2 with TCEP, which was removed with a C8 column and dried under 
vacuum for room-temperature storage. BCA reagent was used to ensure purity by checking for 
brown discoloration in DGSH samples from remaining TCEP. 
As glutathione products were more reactive in slightly basic conditions, 50 mM SPB at 
pH 8.0 was prepared as previously described and used to suspend GSSG and most DLGDs. Due 
to limited availability of particular DLGDs, some had to be suspended in 0.1 M PB 7.4 for other 
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purposes. Absorbances of suspended DLGDs were measured with an Ocean Optics 
spectrophotometer linked to SpectraSuite. Each absorbance was converted to [DLGD] using 
Beer’s Law, where the path length multiplied by the molar absorptivity of the dansyl label (εb) 
was 4300 M-1. 
SDS-PAGE samples with non-fluorescent modifying agents were quenched and labeled 
with 25 mM iodoacetamidofluorescein (IAF, Thermo Scientific Pierce) in DMF. Fluorescent 
labeling with DLGDs was quenched with 500 mM iodoacetamide (IAM, Thermo Fisher 
Scientific) in DMF. Both IAF and IAM react only with reduced cysteine thiols. All SDS-PAGE 
samples were mixed with equal volumes of sample buffer (SB) + glycerol ± β-mercaptoethanol 
(SB(+) or SB(-)). Samples containing IAF were combined with SB(+); all others were combined 
with SB(-). 
The specifics of each PK reaction set may be found in the attached SUPPLEMENTARY 
DATA, Appendix 2. Reagent and PK concentrations were used to calculate ratios of reagent to 
available PK thiols (written as reagent/PK Cys); equal concentrations of PKM1 (9 
Cys/monomer) and PKM2 (10 Cys/monomer) were assumed to be in each reaction. Calculated 
ratios are provided in the reaction summaries. A sample set of reaction conditions for reactions 
with HOCl is provided in Table 2. 
Sample Vi (µl) [PK] (mM) [HOCl] (mM) HOCl/PK Cys 
1 15 0.0233 0 0 
2 15 0.0233 0.050 0.23 
3 15 0.0233 0.10 0.45 
4 15 0.0233 0.25 1.1 
5 15 0.0233 0.50 2.3 
6 15 0.0233 0.75 3.4 
7 15 0.0233 1.0 4.5 
Table 2: Kinetic Assays with Hypochlorous Acid 
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PART III: DATA ANALYSIS AND RESULTS 
 
A. Kinetic Data Analysis 
PK activity was tracked through changes in NADH absorbance (ΔA) over five minutes. 
Overall ΔA’s were typically proportional to the slopes of kinetic curves produced. However, in 
some cases, these curves were not linear. As ΔA values were easier to manipulate and interpret 
in such cases, they were used for comparing relative PK activities. ΔA was converted to change 
in NADH concentration (Δ[NADH]) over five minutes using Beer’s Law, where the path length 
of the plate reader multiplied by the molar absorptivity of NADH (εb) was 3817 ± 63 M-1. PK 
dilution factors and monomer MW (57 kDa) were used to convert these values to Δ[NADH] for 
1 M PK samples. Δ[NADH] averages and standard deviations were calculated and plotted for 
comparison. 
Sample reactions were repeatedly checked with two standards: a STris 7.4 blank and a 
190 μl STris 7.4 + 10 μl NADH control. Absorbance measurements of NADH controls typically 
fell between 1.350 and 1.650 OD with an average Δ[NADH] of -0.01 ± 0.03 OD over five 
minutes due to air exposure. This average was calculated from 74 NADH controls and used to 
correct all PK activities measured. 
Control assays with PK modified by the highest reagent concentrations and in which PEP 
was replaced with STris 7.4 were also performed for each reaction type. These controls would 
identify NADH oxidation or reduction outside of the PK-LDH mechanism by unquenched 
reagents that would reduce confidence in the assay’s ability to reflect PK activity. While controls 
produced ΔA’s that varied from slightly positive to slightly negative values, these values did not 
significantly vary from ΔA’s resulting from natural NADH oxidation by air exposure (i.e., fall 
far outside of the first standard deviation of the NADH control ΔA). Thus, the results of the 
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assays performed could be attributed to PK thiol modifications rather than fluctuating NADH 
redox state. 
B. Examining SDS-PAGE 
SDS-PAGE results were generally qualitative. IAF labeling of PK generally decreased 
with increasing concentrations of thiol-modifying agent—as is shown in the IAF-labeled gel in 
Figure 7 below—while DLGD labeling increased with increasing thiol modification.  
 
 
 
 
 
 
 
Two bands were visible on SDS-PAGE for every PK sample run. The higher molecular 
weight (MW) band corresponds to the PK monomer at 57 kDa. The lower band is suspected to 
be a degraded PK fragment. It contains cysteine residues susceptible to labeling and responds to 
oxidation similarly to the PK band. The presence of degraded PK in this lower band might have 
introduced error into SDS-PAGE analyses, as it would indicate that the amount of protein in the 
PK band did not accurately reflect the amount of PK in each sample. Once an appropriate 
antibody is found, a Western Blot will be performed to confirm that this is the case. However, 
assuming that the same amount of degraded enzyme would consistently appear in the lower 
bands, it would be reasonable to attribute the trends exhibited by the PK monomer bands to 
changes in redox state as opposed to protein concentration. Thus, all other SDS-PAGE images 
include only those bands known to correspond to the enzyme. 
1 2 3 4 5 6 7 
Figure 7: Whole Gel Image of Oxidation by HOCl (+ Low MW Bands) 
IAF labeling. Lane 1: Control; Lane 2: PK + 0.050 mM HOCl; Lane 3: PK + 0.10 mM HOCl; Lane 4: PK + 
0.25 mM HOCl; Lane 5: PK + 0.50 mM HOCl; Lane 6: PK + 0.75 mM HOCl; Lane 7: PK + 1.0 mM HOCl. 
PK 
Suspected PK Fragment 
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PK samples oxidized with D1 exhibited fluorescent smearing starting below the PK band 
and passing through the lower band. No smearing was seen for samples with D2 or DGSH. This 
smearing was consistent for all D1-modified samples and has been observed in previous gels run 
with D1 alone and mixed samples of D1 and creatine kinase or LDH. Smearing intensity appears 
to be proportional to [D1] and likely comes from degraded D1. An example of this is provided in 
Figure 8. 
 
 
 
 
 
 
 
 Relative fluorescence intensities were calculated for IAF labeling of DTNB-, HOCl-, and 
DTNB-/HOCl- + DTT-/TCEP-modified PK samples from SDS-PAGE images. Average 
intensities were calculated from mean intensity values measured using the Image Lab program 
volumetric tool for each sample type. These averages were then converted to percentages of the 
average control IAF labeling intensity. Relative fluorescence intensity values are displayed 
alongside kinetic data as a means of correlating modification and loss of labeling to activity loss. 
C. Activity and Labeling of Unmodified Pyruvate Kinase 
 
To analyze the effects of thiol modification on PK activity, it was necessary to first 
determine the activity of unmodified PK. Consequently, for almost every reaction set outlined, a 
PK sample was also incubated without reagent. These samples were used as individual controls 
to differentiate between the effects of thiol modification and natural changes experienced by PK 
Figure 8: Whole Gel Image of S-glutathiolation by D1 
Lane 1: Control; Lane 2: PK + 1.5 mM D1; Lane 3: PK + 7.4 mM D1; Lane 4: PK + 15 mM D1. 
1 2 3 4 
PK 
Suspected PK Fragment D1 Smearing 
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alone under the experimental conditions. This removed confounding factors like incubation time, 
temperature, and air exposure on activity and ensured that any changes observed could be 
attributed solely to modification of PK thiols. While separate controls were used for daily 
comparisons, data accumulated from all unmodified PK assays were used to calculate an 
estimate of PK activity under the experimental conditions. 
It may appear problematic that these controls were conducted in different buffers with 
different pH values (SPB 7.4, STris 7.4, SPB 8.0, and 0.1 M PB 7.4); conceivably, these 
differences could alter PK activity. However, all PK samples were eventually diluted to 1:100 in 
STris 7.4, and all assay reactions were performed in mostly STris pH 7.4 (180 μl, including 
solvents for assay reagents, in 200 μl total). The sheer volume of STris 7.4 mediated pH and 
buffer differences in the original redox reactions and eliminated pH and buffer type as 
confounding factors in activity changes exhibited. 
Although all PK came from the same source and was purified with the same desalting 
procedure, it exhibited a wide range of activity. Unmodified PK at 1 M produced Δ[NADH] 
values over five minutes ranging from 2.6 x 104 M to 7.3 x 104 M. On average, 1 M PK could 
cause the conversion of (5 ± 1) x 104 M NADH to NAD+ over five minutes (n = 80) under 
standard reaction conditions. 
Unmodified PK controls were also run with each set of modification reactions on SDS-
PAGE. In cases of IAF labeling, controls exhibited substantial fluorescence from labeling of 
reduced cysteine residues. In cases where DLGDs were used for modification, controls exhibited 
no fluorescence. 
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D. Oxidation by Hydrogen Peroxide 
Tabular and graphical versions of changes in PK activity with increasing [H2O2] are 
provided in Table 3 and Figure 9. 
Sample [H2O2] (mM) H2O2/PK Cys Δ[NADH]/M PK (M) Std. Dev. (M) 
1 0 0 5 x 104 1 x 104 
2 0.23 0.75 5.4 x 104 0.4 x 104 
3 0.46 1.5 6.1 x 104 0.5 x 104 
4 0.91 3.0 5.9 x 104 0.2 x 104 
5 2.3 7.5 5 x 104 1 x 104 
6 4.6 15 4 x 104 1 x 104 
7 9.1 30. 3.7 x 104 0.5 x 104 
Table 3: Activity of H2O2-Oxidized Pyruvate Kinase 
 
 
Figure 9: Comparison of H2O2-Oxidized Pyruvate Kinase Activity 
Little to no detrimental impact on enzyme activity was observed with small amounts of 
H2O2. In fact, average activity increased slightly at low [H2O2] until the concentration reached 
0.91 mM, though this increase was well within the standard error of the control’s activity. Above 
0.91 mM, a slight decrease in activity was observed, but up to [H2O2] of 4.6 mM there was 
significant overlap in the standard errors of these average activities and that of un-oxidized PK. 
Activity fell to 3.7 ± 0.5 x 104 M when [H2O2] reached 9.1 mM, falling outside the first standard 
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deviation of the control activity and demonstrating substantial activity loss. Compared to other 
thiol-modifying agents used for these studies, H2O2 produced a relatively weak response in PK 
activity. 
PK oxidation by peroxide was then analyzed using IAF labeling on SDS-PAGE. The 
results of the gels run are shown in Figure 10. 
 
 
 
 
There was a slight increase in IAF labeling of PK thiols from the control to the enzyme 
oxidized with both lower and higher [H2O2], indicating that more cysteine residues in the protein 
were available for labeling with added peroxide. Other residues in the protein may have been 
oxidized to produce structural changes that exposed more cysteine residues for labeling. 
E. S-glutathiolation with Glutathione and Dansyl-Labeled Glutathione Derivatives 
The results of kinetic assays with GSSG are shown in Table 4 and Figure 11; those with 
D1 are displayed in Table 5 and Figure 12. 
Sample [GSSG] (mM) GSSG/PK Cys Δ[NADH]/M PK (M) Std. Dev. (M) 
1 0 0 5.1 x 104 0.9 x 104 
2 0.67 3.0 5.5 x 104 0.6 x 104 
3 3.0 14 4.6 x 104 0.8 x 104 
4 6.7 30. 5.4 x 104 0.7 x 104 
5 13 60. 5.0 x 104 0.8 x 104 
6 15 68 5.0 x 104 0.6 x 104 
7 30. 140 5.1 x 104 0.8 x 104 
Table 4: Activity of GSSG-Modified Pyruvate Kinase 
Figure 10: Oxidation by H2O2 
IAF labeling. Lane 1: Control; Lane 2: PK + 0.50 mM H2O2; Lane 3: PK + 
5.0 mM H2O2. Images were cropped for comparison. 
1 2 3 
PK 
Cysteine Thiols in Pyruvate Kinase Activity 22 
 
 
 
 
Figure 11: Comparison of GSSG-Modified Pyruvate Kinase Activity 
 
Sample [D1] (mM) D1/PK Cys Δ[NADH]/M PK (M) Std. Dev. (M) 
1 0 0 5 x 104 1 x 104 
2 2.6 12 5.5 x 104 0.4 x 104 
3 3.0 14 5.5 x 104 0.8 x 104 
4 15 67 4.9 x 104 0.8 x 104 
5 20. 91 5.0 x 104 0.5 x 104 
Table 5: Activity of D1-Modified Pyruvate Kinase 
 
 
Figure 12: Comparison of D1-Modified Pyruvate Kinase Activity 
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Little change in activity was observed from S-glutathiolation with either GSSG or D1 
over the range of concentrations used. Slight fluctuations in activity were observed, but all 
measured values typically fell within the first standard deviation of the control’s activity. 
Kinetic assays were also performed to examine the effects of S-glutathiolation by other 
DLGDs on activity. This data is shown in Table 6 and Figure 13.  
Sample [DLGD] (mM) DLGD/PK Cys [H2O2] (mM) Δ[NADH]/M PK (M) Std. Dev. (M) 
1 0 0 0 3.8 x 104 0.7 x 104 
2 0.50 D1 6.3 0 3.9 x 104 0.7 x 104 
3 1.0 D1 13 0 4.5 x 104 0.8 x 104 
4 0.50 D2 6.3 0 5.2 x 104 0.7 x 104 
5 1.0 D2 13 0 3.1 x 104 0.6 x 104 
6 0.50 DGSH 6.3 0 4.4 x 104 0.5 x 104 
7 1.0 DGSH 13 0 3.1 x 104 0.8 x 104 
8 0.50 DGSH 6.3 1.4 3.0 x 104 0.5 x 104 
9 1.0 DGSH 13 1.4 3.0 x 104 0.5 x 104 
Table 6: Activity of DLGD-Modified Pyruvate Kinase 
 
 
 
Figure 13: Comparison of DLGD-Modified Pyruvate Kinase Activity 
 
D1 again induced no significant reduction in PK activity from that of the control; it 
actually increased activity on average when 1.0 mM D1 was used. D2 and DGSH without H2O2 
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at 0.50 mM slightly increased PK activity, but at 1.0 mM their addition caused a loss of activity. 
Similar activity loss was observed with both 0.50 mM and 1.0 mM DGSH with added H2O2. 
However, PK after any S-glutathiolation could still effectively operate in vitro to a substantial 
degree. 
SDS-PAGE gels were run to examine DLGD cysteine modification. D1 and D2 labeling 
were directly compared in Figure 14. 
 
 
 
 
D1 labeling at 1.0 mM was about twice the intensity of that observed after modification 
with 0.50 mM D1; labeling with 1.0 mM D2 was about 1.5 times as intense as labeling from 0.50 
mM D2. D1 labeling at both 0.50 mM and 1.0 mM was about a third to half the intensity of the 
corresponding D2 bands, indicating that D1 modified fewer thiols than did D2 at similar 
concentrations. These results may be due, in part, to the fact that half of the reactive thiols in D1 
are unlabeled. If any of these S-glutathiolated the protein, the modified protein would not 
fluoresce. This hypothesis is supported by other SDS-PAGE analyses comparing D1- and D2-
modified PK fluorescence. [D2] here was half [D1]. Both modifications yielded almost the same 
amount of fluorescent labeling at higher concentrations, as is shown in Figure 15.  
 
 
 
 
Figure 14: S-glutathiolation by D1 and D2 
Lane 1: Control; Lane 2: PK + 0.50 mM D1; Lane 3: PK + 1.0 mM D1; Lane 4: PK + 0.50 mM D2; Lane 5: PK 
+ 1.0 mM D2. 
1 2 3 4 5 
PK 
1 2 3 4 5 6 7 
Figure 15: S-glutathiolation by D1 and D2 at ½[D1] 
Lane 1: Control; Lane 2: PK + 1.5 mM D1; Lane 3: PK + 7.4 mM D1; Lane 4: PK + 15 mM D1; Lane 5: PK + 0.74 
mM D2; PK + 3.7 mM D2; PK + 7.4 mM D2. 
PK 
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D2 labeling was then compared to that of DGSH with and without H2O2 as shown in 
Figure 16.  
 
 
 
 
PK modified with 0.50 mM and 1.0 mM DGSH without H2O2 fluoresced with similar 
intensities. Both samples displayed double or triple the intensity of D2-labeled PK at 1.0 mM, 
indicating that DGSH more effectively modified PK thiols than both D2 and D1. DGSH with 
H2O2 showed a clear disparity between labeling at 0.50 mM and at 1.0 mM—the latter was about 
two to three times as intense as the former. Labeling with 0.50 mM DGSH with H2O2 was 
slightly more intense than both 0.50 mM and 1.0 mM DGSH without it. 
Finally, modification was examined as a function of PK reaction time with D1 or D2. The 
results of this analysis are shown in Figures 17 and 18.  
 
 
 
 
 
 
 
 
 
1 2 3 4 5 
Figure 17: S-glutathiolation by D1 over Time 
PK + 8.3 mM D1. Lane 1: 0 min; Lane 2: 2 min; Lane 3: 5 min; Lane 4: 10 min; Lane 5: 20 min. 
PK 
Figure 18: S-glutathiolation by D2 over Time 
PK + 4.9 mM D2. Lane 1: 0 min; Lane 2: 2 min; Lane 3: 5 min; Lane 4: 10 min; Lane 5: 20 min. Images 
were cropped for comparison. 
1 2 3 4 5 
PK 
Figure 16: S-glutathiolation by DLGDs 
Lane 1: Control; Lane 2: PK + 0.50 mM D2; Lane 3: PK + 1.0 mM D2; Lane 4: PK + 0.50 mM DGSH; 
Lane 5: PK + 1.0 mM DGSH; Lane 6: PK + 0.50 mM DGSH + 1.4 mM H2O2; Lane 7: PK + 0.50 mM 
DGSH + 1.4 mM H2O2.   
1 2 3 4 5 6 7 
PK 
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PK that reacted with D1 or D2 for no time showed essentially no labeling. Fluorescence 
reached maximal intensity after two minutes’ reaction time, indicating that S-glutathiolation of 
cysteines modified by DLGDs was a relatively rapid process. 
F. Thiol Modification with Ellman's Reagent 
The results of kinetic analysis of DTNB-modified PK are shown in Table 7 and Figure 
19, while the results of SDS-PAGE analysis are provided in Figure 20. Shown also in Table 7 
are the relative IAF labeling intensities of the DTNB-modified PK bands, which are graphically 
represented in Figure 21. 
Sample [DTNB] (mM) DTNB/PK Cys Δ[NADH]/M PK (M) Std. Dev. (M) Relative Fluorescence (%) 
1 0 0 4.6 x 104 0.9 x 104 100. 
2 0.0050 0.023 4.3 x 104 0.8 x 104 101 
3 0.010 0.045 4.5 x 104 0.3 x 104 117 
4 0.050 0.23 4 x 103 2 x 103 118 
5 0.10 0.45 2 x 103 4 x 103 77.7 
6 0.25 1.1 2 x 103 7 x 103 47.5 
7 0.50 2.3 1 x 103 7 x 103 38.3 
Table 7: Activity of DTNB-Modified Pyruvate Kinase 
 
 
Figure 19: Comparison of DTNB-Modified Pyruvate Kinase Activity 
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Figure 21: Relative SDS-PAGE Fluorescence Intensities of DTNB-Modified Pyruvate Kinase 
 
DTNB additions of up to 0.010 mM did not significantly reduce PK activity. With 0.050 
mM DTNB, though, PK activity fell dramatically. Activity disappeared at that [DTNB] and all 
higher concentrations used. It was thus apparent that some DTNB/PK Cys ratio between 0.045 
and 0.23 was necessary to eliminate all enzymatic activity. 
IAF labeling of DTNB-modified PK displayed a slightly different trend. SDS-PAGE 
analysis demonstrated that little labeling was lost until [DTNB] reached 0.10 mM; in fact, 
labeling intensity appeared to increase by about 15-20% with respect to that of the control at 
DTNB concentrations of 0.010 mM and 0.050 mM. At and beyond 0.10 mM, though, 
fluorescence declined steadily with increasing [DTNB] until the concentration reached 0.50 mM, 
after which about 38% of the original label remained. 
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Figure 20: Modification of Cysteine Thiols by DTNB 
IAF labeling. Lane 1: Control; Lane 2: PK + 0.0050 mM DTNB; Lane 3: PK + 0.010 mM DTNB; Lane 4: 
PK + 0.050 mM DTNB; Lane 5: PK + 0.10 mM DTNB; Lane 6: PK + 0.25 mM DTNB; Lane 7: PK + 0.50 
mM DTNB. 
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G. Oxidation by Hypochlorous Acid 
The results of HOCl activity studies are provided in Table 8 and Figure 22; Table 8 also 
displays the relative IAF labeling intensity values of HOCl-oxidized PK. SDS-PAGE results are 
shown in Figure 23, while the relative intensity values are graphically represented in Figure 24. 
Sample [HOCl] (mM) HOCl/PK Cys Δ[NADH]/M PK (M) Std. Dev. (M) Relative Fluorescence (%) 
1 0 0 4 x 104 2 x 104 100. 
2 0.050 0.23 5 x 104 1 x 104 96.8 
3 0.10 0.45 3.4 x 104 0.7 x 104 98.0 
4 0.25 1.1 1.6 x 104 0.3 x 104 52.6 
5 0.50 2.3 1.1 x 104 0.6 x 104 24.9 
6 0.75 3.4 1 x 103 3 x 103 19.0 
7 1.0 4.5 3 x 103 3 x 103 15.7 
Table 8: Activity of HOCl-Oxidized Pyruvate Kinase 
 
 
Figure 22: Comparison of HOCl-Oxidized Pyruvate Kinase Activity 
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Figure 23: Oxidation by HOCl 
IAF labeling. Lane 1: Control; Lane 2: PK + 0.050 mM HOCl; Lane 3: PK + 0.10 mM HOCl; Lane 4: PK + 0.25 mM 
HOCl; Lane 5: PK + 0.50 mM HOCl; Lane 6: PK + 0.75 mM HOCl; Lane 7: PK + 1.0 mM HOCl. 
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Figure 24: Relative SDS-PAGE Fluorescence Intensities of HOCl-Modified Pyruvate Kinase 
 
Similar to the curves produced by reactions with H2O2, D2, and DGSH without H2O2, PK 
activity increased slightly at low [HOCl], reaching a maximum at 0.050 mM. This maximum 
was within the standard error of the activity of the control. Beyond this concentration activity 
decreased with increasing [HOCl] until it disappeared at 0.75 mM. 
The results in Figure 24 present a trend in labeling similar to that of the activity. Until 
[HOCl] reached 0.10 mM, oxidized PK fluoresced with about the same intensity as that of the 
control. Beyond [HOCl] of 0.10 mM, however, fluorescent labeling declined steadily in a 
concentration-dependent manner. At 0.75 mM and 1.0 mM HOCl, little protein labeling, about 
16% of the original intensity, remained. 
H. Oxidation-Reduction Studies 
 The reversibility of PK modification was analyzed in two ways: through incubation with 
a thiol-modifying agent followed by a reducing agent, and vice versa. The first method was 
performed by incubating PK with HOCl or DTNB, then by incubating it with or without DTT or 
TCEP. The results of kinetic analysis with these samples are shown in Table 9 and Figure 25, 
while SDS-PAGE data is provided in Figure 26. (In Table 9, MA stands for modifying agent.) 
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Included also in Table 9 are the relative fluorescence intensities of the IAF-labeled samples, 
which are compared graphically in Figure 27.  
Sample [MA1] (mM) MA1/PK Cys [MA2] (mM) MA2/PK Cys 
Δ[NADH]/M PK 
(M) Std. Dev. (M) 
Relative 
Fluorescence (%) 
1 0 0 0 0 4 x 104 1 x 104 100. 
2 0.50 HOCl 2.3 0 0 6 x 103 3 x 103 30.7 
3 0.50 HOCl 2.3 4.0 DTT 20. 1.3 x 104 0.4 x 104 193 
4 0.50 HOCl 2.3 4.0 TCEP 20. 1.3 x 104 0.7 x 104 202 
5 0.50 DTNB 2.3 0 0 3 x 103 6 x 103 45.1 
6 0.50 DTNB 2.3 4.0 DTT 20. 7 x 103 7 x 103 210. 
7 0.50 DTNB 2.3 4.0 TCEP 20. 3 x 103 6 x 103 201 
Table 9: Activity of HOCl-/DTNB- and DTT-/TCEP-Modified Pyruvate Kinase 
 
 
Figure 25: Comparison of HOCl-/DTNB- and DTT-/TCEP-Modified Pyruvate Kinase Activity 
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Figure 26: Oxidation by HOCl/DTNB and Reduction by DTT/TCEP 
IAF labeling. Lane 1: Control; Lane 2: PK + 0.50 mM HOCl; Lane 3: PK + 0.50 mM HOCl + 4.0 mM DTT; Lane 4: 
PK + 0.50 mM HOCl + 4.0 mM TCEP; Lane 5: PK + 0.50 mM DTNB; Lane 6: PK + 0.50 mM DTNB + 4.0 mM DTT; 
Lane 7: PK + 0.50 mM DTNB + 4.0 mM TCEP. 
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Figure 27: Relative SDS-PAGE Fluorescence Intensities of HOCl-/DTNB- and DTT-/TCEP-Modified Pyruvate Kinase 
 
All PK activity was lost with the addition of 0.50 mM DTNB, while most activity 
disappeared with 0.50 mM HOCl. Following these thiol modifications with either 4.0 mM DTT 
or 4.0 mM TCEP produced mixed results. Both DTT and TCEP were able to restore about a third 
of the HOCl-oxidized PK’s activity. The results of TCEP reduction are more uncertain due to the 
overlap between its first standard deviation and that of HOCl-oxidized PK. Original activity was 
more difficult to restore after modification by DTNB. TCEP restored essentially no activity with 
respect to the modified sample, while DTT salvaged only about 18% of the control activity. 
 The results of SDS-PAGE analysis of the same samples demonstrated that DTT and 
TCEP could reduce cysteine residues after modification. The control emits intense fluorescence 
that is reduced to a fraction of its original level with modification by either 0.50 mM HOCl or 
0.50 mM DTNB. (HOCl produces greater loss of labeling.) Additions of DTT or TCEP to either 
modified sample yields substantial increases in protein labeling. Reduction appears to make a 
marginally bigger impact with DTNB-oxidized PK than with HOCl-oxidized PK. More 
noticeable still is that this labeling is about 100% more intense than that of the control, indicating 
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that significant numbers of cysteine residues, including ones that were originally unlabeled in 
unmodified PK, reacted with IAF. 
 Because previous evidence supported the ability of reducing agents like DTT to restore 
significantly more PK activity after DTNB thiol modification, another experiment was 
performed in which a small amount of PK was reacted with a low [DTNB] and overwhelmed 
with much higher [DTT] or [TCEP]. (Because [PK] was so small in these reactions, the sample 
was only diluted to 1:5 in STris 7.4. Controls run with these still exhibited little variation from 
the standard ΔA of NADH due to air oxidation.) These reactions produced the results provided in 
Table 10 and Figure 28. 
Sample [DTNB] (mM) DTNB/PK Cys [MA2] (mM) MA2/PK Cys Δ[NADH]/M PK (M) Std. Dev. (M) 
1 0 0 0 0 3.3 x 104 0.3 x 104 
2 0.083 6.0 0 0 0 4 x 103 
3 0.083 6.0 15. 150 3 x 103 2 x 103 
4 0.083 6.0 15. 150 1.2 x 104 0.3 x 104 
Table 10: Activity of DTNB- and DTT-/TCEP-Modified Pyruvate Kinase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: Comparison of DTNB- and DTT-/TCEP-Modified Pyruvate Kinase Activity 
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after modification. However, since 150 times the amount of DTT was used for every modified 
residue to produce these results, it would take tremendous concentrations of it to recover all PK 
functionality after DTNB modification. TCEP, on the other hand, restored very little activity, 
potentially because it could not access the functional thiols modified by DTNB. (These results 
may have been due, in part, to leftover DTNB in the samples, but this excess would have been 
quenched quickly by such large amounts of DTT or TCEP, leaving plenty of reducing agent to 
handle modified cysteine residues.) 
 Redox kinetic studies in the other direction (reduction to oxidation) were performed by 
incubating PK with DTT or TCEP, then with H2O2. The results of these assays are shown in 
Tables 11 and 12 and Figures 29 and 30. 
Sample [DTT] (mM) DTT/PK Cys [H2O2] (mM) H2O2/PK Cys Δ[NADH]/M PK (M) Std. Dev. (M) 
1 0 0 0 0 4.9 x 104 0.8 x 104 
2 0.83 3 0 0 6 x 104 1 x 104 
3 0.83 3 7.1 30. 4 x 104 1 x 104 
Table 11: Activity of DTT- and H2O2-Modified Pyruvate Kinase 
 
 
Figure 29: Comparison of DTT- and H2O2-Modified Pyruvate Kinase Activity 
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Sample [TCEP] (mM) TCEP/PK Cys [H2O2] (mM) H2O2/PK Cys Δ[NADH]/M PK (M) Std. Dev. (M) 
1 0 0 0 0 4.7 x 104 0.6 x 104 
2 0.83 3.0 0 0 6.8 x 104 0.8 x 104 
3 0.83 3.0 7.1 30. 5.4 x 104 0.9 x 104 
Table 12: Activity of TCEP- and H2O2-Modified Pyruvate Kinase 
 
 
Figure 30: Comparison of TCEP- and H2O2-Modified Pyruvate Kinase Activity 
 
From this data, one observes that PK activity increased with addition of either TCEP or 
DTT. TCEP reduction yielded more activity relative to reduction by DTT, but both reduced 
species were re-oxidized by the addition of H2O2 and subsequently lost activity. (The impact of 
H2O2 oxidation appeared to be greater in these experiments than it was when it was added to PK 
alone.) The DTT-reduced enzyme after oxidation assumed about the same activity as that of the 
control, while TCEP-reduced PK retained slightly more. These results confirm that redox 
reactions are able to modulate enzymatic structure and function to varying degrees in vitro, 
indicating that PK activity may be responsive to cellular redox conditions. 
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PART IV: DISCUSSION 
The data presented above confirmed the results of other studies citing reduction in PK 
activity as a product of cysteine thiol modification. This occurred in the presence of a number of 
reagents tested, including H2O2, DTNB, HOCl, and, to a lesser extent, GSSG and DLGDs. It also 
revealed that the consequences of cysteine modification in PK could vary significantly based on 
the reagent used. 
A. Oxidation by Hydrogen Peroxide 
H2O2, when compared to some of the other thiol-modifying agents, had a lesser impact on 
PK functionality. H2O2 oxidation yielded limited changes in PK activity, even between un-
oxidized PK and PK oxidized with about 9.1 mM H2O2—an absurdly high concentration given 
normal H2O2 levels in typical cellular environments: greater than 50 µM H2O2 can be enough to 
kill animal, plant, and bacterial cells, so standard [H2O2] within the cell must be less.
25 That 
H2O2 was an inefficient oxidant against PK Cys residues at physiological concentrations was 
expected. These results agree with the fact that H2O2 is a weak thiol-specific oxidant. They also 
line up with the results of a previous study that found that H2O2 oxidative stress had a negligible 
impact on PK activity.26 
Kinetic results were supported by a lack of PK oxidation evident on SDS-PAGE. Under 
normal circumstances, oxidized cysteine-containing proteins should have fewer reduced residues 
available to react with IAF and thus fluoresce less than their unmodified counterparts. This was 
not the case with H2O2-oxidized PK; the oxidized protein, even with 5.0 mM H2O2, fluoresced 
more than the control did on the same gel. This indicated two things. First, the original 
“unmodified” PK used as a control may have been partially oxidized, which could have been the 
result of air exposure during purification and experimentation. (This partial oxidation paved the 
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way for the reduction-oxidation studies discussed later.) If this was the case, it might be assumed 
that PK activity reported here was lower than it would be in vivo.  
Second, H2O2 addition somehow oriented PK in an appropriate environment for labeling 
additional reduced thiols despite the external oxidizing conditions. How this occurred can only 
be speculated: it may be that the enzyme has (a) particular defense mechanism(s) against low 
levels of oxidative stress. This could be reasonable given that cells constantly produce small 
amounts of H2O2 and other cellular oxidants that linger until they are eliminated by antioxidants 
or antioxidant enzymes like catalase. PK interactions with PEP and NADH have already been 
shown to improve PK activity in the presence of H2O2, and PK’s production of pyruvate limits 
oxidative stress by converting H2O2 to H2O.
26 
While these interactions would explain the results of the kinetic studies, the same trend 
was also observed on SDS-PAGE where PK did not mix with these substances. Consequently, it 
might be guessed that PK defenses against oxidation also include other residues that are modified 
in place of thiols, especially functionally important ones. PK activity and labeling may thus be 
partially dependent upon structural alteration in a slightly oxidizing environment. Small amounts 
of H2O2 may oxidize other PK residue(s) to induce a more active conformation that also exposes 
other cysteine residues without oxidizing them, yielding the increased activity and labeling 
observed at low [H2O2].  
B. S-glutathiolation with Glutathione and Dansyl-Labeled Glutathione Derivatives 
The results above demonstrate that GSSG oxidation caused little change in PK activity. 
[GSSG] as high as 15 mM and 30 mM caused essentially no activity loss. These results show 
that GSSG is an inefficient PK functional thiol-modifying agent. One of glutathione’s major 
roles in the cell may account for its inability to permanently damage PK. It oxidizes readily and 
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S-glutathiolates proteins to protect them from oxidative stress. When the stress subsides, it must 
release from these proteins, reduce, and be recycled for future use. GSSG S-glutathiolation of PK 
must therefore be easily reversible, so GSSG alone could feasibly only transiently modify 
functionally-relevant thiols and thus not seriously impair PK without additional oxidative stress. 
It also may be that GSSG, due to its size and hydrophilic nature, prefers to react with other, more 
exposed and hydrophilic thiols or residues, preventing GSSG from reaching and modifying 
functionally-relevant cysteine residues towards the hydrophobic interior of the protein. 
As was mentioned earlier, the structure of PK may have evolved to operate optimally in 
slightly oxidizing conditions within the cell. This coping strategy would be especially useful for 
a modifying agent that, in periods of oxidative stress, could potentially reach cellular 
concentrations in the mM range, given that oxidizable glutathione in the cell can be found at 
concentrations of up to 10 mM.26  
D1 fared little better than GSSG at reducing PK activity. Its impact was minimal at all 
concentrations, and low [D1] actually appeared to improve PK function. When analyzed via 
SDS-PAGE, though, it was evident that D1 did modify some PK sulfhydryls. Fluorescent dansyl 
labeling was observed with the addition of 0.50 mM D1 and appeared to increase in a 
concentration-dependent manner. Based on the results of the time course gel analyses, labeling 
reached a maximum quickly, typically within two minutes of incubation time at room 
temperature. Despite this, D1 was the weakest S-glutathiolating agent of the DLGDs.  
D2 S-glutathiolation yielded significant PK labeling—about twice to three times greater 
in intensity than D1 labeling as seen with SDS-PAGE. Addition of higher [D2] also 
demonstrated that D2 labeling increased in a concentration-dependent manner, and time courses 
showed that, like D1 modification, D2 modification reached a maximum within about two 
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minutes of reaction time with the protein at room temperature. Unlike D1, however, D2 actually 
altered PK activity. Activity changes resembled those seen with H2O2 oxidation: lower [D2] 
increased PK activity, falling in line with the contention that PK is optimized to work in slightly 
oxidizing conditions; higher [D2] decreased activity substantially. D2 may more permanently 
inhibit PK activity than GSSG or D1 because it contains more hydrophobic, sterically-hindered 
dansyl labels (on either end of the molecule) that could interact with more functional PK thiols. 
(While D1 also had a dansyl-labeled end, the unlabeled end likely competed with it for access to 
PK thiols and interfered with its ability to react, reducing its impact on protein labeling and 
functionality when compared to that of D2.) 
DGSH S-glutathiolation without H2O2 operated similarly to D2 S-glutathiolation: it 
increased PK activity at low [DGSH] and decreased activity at higher [DGSH]. S-glutathiolation 
with 1.0 mM DGSH reduced PK activity to the same value as modification with 1.0 mM D2. 
Despite these similarities, DGSH labeling at 0.50 mM and 1.0 mM appeared to be about 1.5 
times as intense as 1.0 mM D2 labeling. PK labeling occurred with DGSH because the enzyme 
was partially oxidized and could thus disulfide exchange with the reduced molecule. 
While DGSH alone induced changes in PK activity and labeling, it was most effective 
when paired with H2O2. It is unknown as to whether H2O2 oxidized the protein or DGSH first, 
but in either case it opened up more opportunities for disulfide exchange. Much more labeling—
about two to three times greater—was observed at both 0.50 mM and 1.0 mM when compared to 
DGSH labeling without oxidant. However, the extent of activity loss in the enzyme from 0.50 
mM and 1.0 mM DGSH and H2O2 was the same as that observed with 1.0 mM D2 or DGSH 
alone. This suggests that there exists a plateau for activity loss as a product of S-glutathiolation 
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by DLGDs at concentrations of up to 1.0 mM; H2O2 appeared to simply accelerate the process 
and reduce the amount of DLGD necessary to reach this plateau. 
Comparing the results of kinetic analyses to those of SDS-PAGE demonstrates a disparity 
between the oxidation of thiols involved in PK labeling and those involved in PK function. The 
case of D1 highlights this especially: D1 caused no activity loss despite a concentration-
dependent increase in labeling. This inconsistency implies that D1 does modify PK cysteine 
residues; however, these residues are not important for maintaining PK activity. Modified 
sulfhydryls may be located in more exposed, hydrophilic areas or be generally more reactive. 
The DLGDs, like GSSG, tended to selectively react with these thiols over those responsible for 
maintaining PK activity, yielding restricted activity loss despite increases in labeling. These 
thiols may act as part of the hypothesized defense mechanism against oxidation mentioned 
previously. 
C. Thiol Modification with Ellman’s Reagent 
The kinetic analyses discussed above confirm DTNB’s potency as a thiol-modifying 
agent and PK inhibitor. Activity is completely lost at extremely low [DTNB] (0.050 mM). At 
concentrations below 0.050 mM, though, little to no change in activity is observed, implying that 
a threshold [DTNB] is necessary to modify all thiols involved in PK activity. This threshold falls 
between 0.045 and 0.23 DTNB molecules per available cysteine residue. 
SDS-PAGE analysis provides additional insight into DTNB modification. Adding 
[DTNB] below 0.010 mM causes little to no change in IAF labeling when compared to that of 
the unmodified enzyme. This supports associated kinetic data and suggests that DTNB is simply 
ineffective as a thiol-modifying agent below a certain threshold concentration. However, 
between 0.010 mM and 0.050 mM DTNB causes a 15-20% increase in labeling, indicating that it 
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modifies the protein structure in such a way as to yield increased thiol labeling; above this 
threshold, labeling decreases in a concentration-dependent manner. This data directly contrasts 
with the complete inhibition of PK activity observed at 0.050 mM DTNB. 
This disparity could be explained by a selective preference of the smaller, more 
hydrophobic DTNB for hydrophobic cysteine residue(s) located towards the center of the protein 
and responsible for PK functionality. If this is true, DTNB would modify Cys358 and other 
functional cysteine residue(s, if any) and alter protein structure before it modified those exposed, 
more hydrophilic residues readily labeled by IAF. After all activity was lost, DTNB would 
interact with other exposed thiols and reduce PK labeling. This would explain the trends in both 
the kinetic data and SDS-PAGE analyses. 
Under normal circumstances, exposed, hydrophilic PK residues more readily accessed by 
IAF could serve to protect functionally-important thiols from oxidative stress. DTNB, however, 
bypassed these residues and interacted directly with more important interior thiol(s). Given that 
DTNB is neither produced in the body nor typically ingested, it would be reasonable for the 
enzyme to lack defenses particular to DTNB-induced stress and only ward off stress from more 
commonly produced cellular oxidants like H2O2 and GSSG. 
D. Oxidation by Hypochlorous Acid 
HOCl, like DTNB, is an effective oxidant for PK cysteine residues, though it takes about 
15 times more HOCl than DTNB to achieve full activity loss. As it does with oxidative stress 
from H2O2 and DLGDs, PK activity actually increases with low [HOCl], again lending support 
to the notion that PK is optimized to function under slightly oxidizing cellular conditions. 
Beyond this point, though, and unlike DTNB, PK activity decreases in a concentration-
dependent manner until all activity is lost at 0.75 mM HOCl. This concentration is much higher 
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than concentrations typically observed in cells even during neutrophil immune response, which 
fall in the µM range.27 SDS-PAGE results exhibit the same trend: IAF labeling stays relatively 
constant or increases slightly at low [HOCl], after which it decreases steadily in a concentration-
dependent manner. 
From these results, it could be concluded that HOCl is a potent thiol oxidant; however, it 
is less selective for particular cysteine residues than the DLGDs or DTNB. It is equally likely to 
react with sulfhydryls readily labeled by IAF as it is with Cys358 and more functionally-relevant 
thiols. Consequently, more exposed, reactive sulfhydryls could deter oxidation of thiols like 
Cys358 to a limited extent and thus constitute part of the hypothesized PK defense mechanism 
against low oxidative stress (such as from physiologically relevant µM HOCl concentrations). 
Since cells do not cope with [HOCl] in the mM range even during immune response, it is 
reasonable for HOCl concentrations approaching 0.75 mM and 1.0 mM to overwhelm this 
proposed defense mechanism, should it exist. 
E. Oxidation-Reduction Studies 
Studies conducted by previous research groups with DTNB and DTT exposed the 
reversible nature of PK thiol oxidation and activity loss. In these studies, PK activity was 
eliminated after DTNB modification, but the addition of enough DTT restored about 90% of the 
original functionality. 24 Here, similar scenarios were arranged with different reagents. Two thiol-
modifying agents, HOCl and DTNB, were used to induce (almost) full PK activity loss. 
Modified PK was then reduced with DTT or TCEP and examined for any restoration of activity. 
Reduction of HOCl-oxidized PK with either DTT or TCEP restored activity to about a 
third of its original value, and it is plausible that even higher [DTT] or [TCEP] would restore 
even more activity. Reduction of DTNB-modified PK with those same DTT and TCEP 
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concentrations did little good. On average, TCEP reduction generated no increase in activity 
from that of the DTNB-modified enzyme. Modified PK reduced with DTT fared little better. 
A reassessment of the aforementioned study revealed that PK activity restoration required 
over 5500 times more DTT than there was DTNB-modified enzyme complex.24 As a result, in 
the above experiment there was probably too little DTT or TCEP to reverse DTNB’s effects. 
Another experiment was conducted in which PK was reduced with higher relative concentrations 
of DTT or TCEP to available thiols (about 150 times greater). This produced more evident 
activity restoration with DTT, which constituted a little over a third of the control activity; TCEP 
reduction only regained about 10% of that activity. DTT more effectively “fixed” the DTNB-
modified PK, indicating that it is either more potent against DTNB damage or that it is more 
selective for functionally-relevant thiols, potentially because it is more hydrophobic than TCEP 
and can thus access interior residues. 
Comparing these results to SDS-PAGE data presents major disparities between cysteine 
residues responsible for protein labeling and activity. IAF labeling of the unmodified enzyme all 
but disappeared with added HOCl or DTNB. When reduced by either DTT or TCEP, however, 
the protein exhibited labeling about 100% more intense than that of the control. This suggests 
that thiols responsible for IAF labeling likely do not participate in PK catalysis. It also reiterates 
that some of these more readily labeled residues were at least partially oxidized or oriented such 
that they could not be readily labeled. Finally, these results indicate that DTT and TCEP 
demonstrate a preference for reducing more exposed or reactive cysteine residues over those 
responsible for PK function. DTT appears to show less of this preference than TCEP, at least in 
the case of DTNB modification. 
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Partial oxidation of PK used throughout the year provided an opportunity to observe the 
opposite scenario. This PK was reduced with DTT or TCEP to give the enzyme additional 
activity. Oxidizing the reduced PK with H2O2 could inhibit PK functionality and demonstrate 
redox reversibility in the opposite direction. On average the enzyme gained activity with 
reduction by either reducing agent. (These activity values after reduction may be more reflective 
of PK activity in vivo.) TCEP here appeared to be more effective at increasing enzyme activity 
than DTT, suggesting that it may be less selective for IAF-targeted residues than was originally 
implied by the results of the previous experiment. (Rather, it is probably just a weak counter-
agent to DTNB.) Adding H2O2 lowered PK activity to values around those exhibited by the 
original, partially oxidized enzyme. The overlap in these averages’ standard deviations make 
these results inconclusive, but they imply that changes in enzyme functionality may be adjusted 
back and forth by varying cellular redox conditions in either direction. 
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PART V: CONCLUSIONS 
 Overall, the experiments described above provided new information concerning PK thiol 
reactivity and enzyme functionality. First, they established a baseline range of values for PK 
activity in vitro. Second, they confirmed that cellular PK activity could potentially be modulated 
by varying cellular redox state or otherwise modifying cysteine residues: oxidizing or modifying 
these thiols would decrease activity, while reducing them or removing these modifications would 
increase it. Activity modulation was done with multiple reagents that displayed variable 
preferences for particular PK thiols. How cysteine modification actually impairs the enzyme is 
still unknown: further study is required to identify which (if any besides Cys358) must be 
modified to impair PK function. The action(s) blocked by these modifications—either substrate 
binding or the catalytic mechanism—has (have) yet to be determined, and the exact mechanisms 
by which these reagents “choose” their thiol targets, while they have been hypothesized here, are 
also unknown. 
Third, these studies demonstrated that efficient PK activity is at least partially dependent 
on a slightly oxidizing environment. This dependence may be the result of adaptation to a 
cellular environment that normally contains small amounts of H2O2 (from oxidative 
phosphorylation), HOCl (from neutrophil-mediated immune response), GSSG (from multiple 
systems involving redox mechanisms), and other thiol-modifying agents. The above data also 
suggest that the enzyme may protect itself from extensive modification of functionally-relevant 
thiols by cellular oxidants at physiologically relevant concentrations. This protection may come 
from other amino acids that are altered in their place, but further study is required to identify 
exactly which residues take part in these defense mechanisms, should they exist. Since only a 
few cysteine sulfhydryls are necessary for the protein to function normally, some of these may, 
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in fact, be other cysteine residues. This would be supported by the changes observed in PK 
labeling seen in SDS-PAGE analyses that were not accompanied by changes in PK activity. 
Many questions remain with regards to PK oxidation and how the enzyme functions and 
interacts with other proteins in vivo. However, the results of this study suggest that PK may not 
only act in its typical transferase capacity, but also may function as an antioxidant buffer for 
other nearby proteins that are sensitive to oxidative stress, such as GAPDH and tubulin. 
Considering this, PK oxidation may serve as a marker for high levels of oxidative stress in vivo 
and provoke other cellular antioxidant responses. 
The data presented in this thesis provide a foundation for investigating previously 
unexplored roles for pyruvate kinase in mediating cellular responses to oxidative stress through 
cysteine thiol modification. With any luck, further exploration into PK interactions with thiol-
modifying agents and other proteins like GAPDH and tubulin will yield discoveries that aid in 
understanding the metabolic and structural consequences of cellular oxidative stress. This 
knowledge may then provide ideas as to how to mitigate or reverse oxidative damage in 
vulnerable cellular structures like microtubules, thereby providing a means of defending against 
or reversing the effects of major neurological disorders and other types of diseases. 
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PART IV: SUPPLEMENTARY DATA 
 
Appendix 1: Chemical Index 
Compound Molecular Weight (g/mol) Structure 
Adenosine diphosphate (ADP) 427.2 
 
 
 
 
 
 
 
Phosphoenolpyruvate (PEP) 234.0 
 
 
 
 
 
Pyruvate 88.06 
 
 
 
 
Nicotinamide adenine dinucleotide 
(NADH) 709.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ellman’s reagent (DTNB) 396.3 
 
 
 
 
 
Dithiothreitol, reduced (DTT) 154.3 
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Glutathione, oxidized (GSSG) 612.6 
 
 
 
 
 
 
 
 
 
Single-dansyl-labeled glutathione, 
oxidized (D1) 846.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tris(2-carboxyethyl)phosphine, 
reduced (TCEP) 286.7 
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Double-dansyl-labeled glutathione, 
oxidized (D2) 1081 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dansyl-labeled glutathione, reduced 
(DGSH) 541.2 
 
 
 
Iodoacetamidofluorescein (IAF) 515.2  
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Iodoacetamide (IAM) 185.0  
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Appendix 2: Reaction Conditions 
  
The tables provided in this section present the reaction conditions arranged for each type 
of kinetic and SDS-PAGE experiment discussed in this thesis. In each table, [PK] refers to the 
concentration of active PK monomer in the reaction, Vi is the initial reaction volume of single-
step reactions (without quenching reagent, if used), and V1 and V2 correspond to the first and 
second reaction volumes of two-step reactions (without quenching agent). MA1 and MA2 stand 
for the first and second modifying agents, respectively. All reactions were performed in STris 7.4 
and incubated for 30 minutes at 37 °C unless otherwise stated below the tables. Reactions 
involving H2O2 were quenched with 2 mg/ml catalase; all others were quenched through a 1:100 
dilution of the samples in STris 7.4 unless otherwise stated. 
  
Sample Vi (µl) [PK] (mM) [H2O2] (mM) H2O2/PK Cys Catalase (µl) 
1 22 0.0319 0 0 2 
2 22 0.0319 0.23 0.76 2 
3 22 0.0319 0.46 1.5 2 
4 22 0.0319 0.91 3.0 2 
5 22 0.0319 2.3 7.6 3 
6 22 0.0319 4.6 15 3 
7 22 0.0319 9.1 30. 3 
Table 13: Kinetic Assays with Hydrogen Peroxide 
 
Sample Vi (µl) [PK] (mM) [H2O2] (mM) H2O2/PK Cys 2 mg/ml Catalase (µl) 25 mM IAF (µl) 
1 15 0.0233 0 0 3 1 
2 15 0.0233 0.50 2.3 3 1 
3 15 0.0233 5.0 23 3 1 
Table 14: SDS-PAGE Analysis with Hydrogen Peroxide 
 
Sample Vi (µl)* [PK] (mM) [GSSG] (mM) GSSG/PK Cys 
1 15 0.0233 0 0 
2 15 0.0233 0.67 3.0 
3 15 0.0233 3.0 14 
4 15 0.0233 6.7 30. 
5 15 0.0233 13 59 
6 15 0.0233 15 68 
7 15 0.0233 30 140 
Table 15: Kinetic Assays with Oxidized Glutathione 
*All reactions were performed in SPB 8.0. 
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Sample Vi (µl)* [PK] (mM) [D1] (mM) GSSG/PK Cys 
1 15 0.0233 0 0 
2 15 0.0233 2.6 12 
3 15 0.0233 3.0 14 
4 15 0.0233 15 68 
5 15 0.0233 20 90 
Table 16: Kinetic Assays with Single-Dansyl-Labeled Glutathione 
*All reactions were performed in SPB 8.0. 
 
Sample Vi (µl)* DLGD [PK] (mM) [DLGD] (mM) DLGD/PK Cys [H2O2] (mM) 
1 21 --- 0.00835 0 0 0 
2 21 D1 0.00835 0.50 6.3 0 
3 21 D1 0.00835 1.0 13 0 
4 21 D2 0.00835 0.50 6.3 0 
5 21 D2 0.00835 1.0 13 0 
6 21 DGSH 0.00835 0.50 6.3 0 
7 21 DGSH 0.00835 1.0 13 0 
8 21 DGSH 0.00835 0.50 6.3 1.4 
9 21 DGSH 0.00835 1.0 13 1.4 
Table 17: Kinetic Assays with Various Dansyl-Labeled Glutathione Derivatives 
*All reactions were performed in 0.1 M PB 7.4. 
 
Sample Vi (µl)* DLGD [PK] (mM) [DLGD] (mM) DLGD/PK Cys [H2O2] (mM) 500 mM IAM 
1 15 --- 0.0175 0 0 0 3 
2 15 D1 0.0175 0.50 3.0 0 3 
3 15 D1 0.0175 1.0 6.0 0 3 
4 15 D2 0.0175 0.50 3.0 0 3 
5 15 D2 0.0175 1.0 6.0 0 3 
6 15 DGSH 0.0175 0.50 3.0 0 3 
7 15 DGSH 0.0175 1.0 6.0 0 3 
8 15 DGSH 0.0175 0.50 3.0 1.4 3 
9 15 DGSH 0.0175 1.0 6.0 1.4 3 
Table 18: SDS-PAGE Analysis with Various Dansyl-Labeled Glutathione Derivatives 
*All reactions were performed in 0.1 M PB 7.4. 
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Sample Vi (µl)* DLGD [PK] (mM) [DLGD] (mM) DLGD/PK Cys 500 mM IAM 
1 15 --- 0.0233 0 0 3 
2 15 D1 0.0233 1.5 6.8 3 
3 15 D1 0.0233 7.4 33 3 
4 15 D1 0.0233 15 68 3 
5 15 D2 0.0233 0.74 3.3 3 
6 15 D2 0.0233 3.7 17 3 
7 15 D2 0.0233 7.4 33 3 
Table 19: SDS-PAGE Analysis of [D1] and [D2] on Labeling 
*All reactions were performed in SPB 8.0. 
 
Sample Vi (µl)* DLGD [PK] (mM) [DLGD] (mM) DLGD/PK Cys 500 mM IAM Time (min) 
1 15 D1 0.0233 8.3 37 3 0 
2 15 D1 0.0233 8.3 37 3 2 
3 15 D1 0.0233 8.3 37 3 5 
4 15 D1 0.0233 8.3 37 3 10 
5 15 D1 0.0233 8.3 37 3 20 
6 15 D2 0.0233 4.2 19 3 0 
7 15 D2 0.0233 4.2 19 3 2 
8 15 D2 0.0233 4.2 19 3 5 
9 15 D2 0.0233 4.2 19 3 10 
10 15 D2 0.0233 4.2 19 3 20 
Table 20: SDS-PAGE Analysis of D1 and D2 Labeling Time Courses 
*All reactions were performed in SPB 8.0 and at room temperature. 
 
Sample Vi (µl) [PK] (mM) [DTNB] (mM) DTNB/PK Cys 
1 15 0.0233 0 0 
2 15 0.0233 0.0050 0.023 
3 15 0.0233 0.010 0.045 
4 15 0.0233 0.050 0.23 
5 15 0.0233 0.10 0.45 
6 15 0.0233 0.25 1.1 
7 15 0.0233 0.50 2.3 
Table 21: Kinetic Assays with Ellman’s Reagent 
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Sample Vi (µl)* [PK] (mM) [DTNB] (mM) DTNB/PK Cys 25 mM IAF (µl) 
1 15 0.0233 0 0 1 
2 15 0.0233 0.0050 0.023 1 
3 15 0.0233 0.010 0.045 1 
4 15 0.0233 0.050 0.23 1 
5 15 0.0233 0.10 0.45 1 
6 15 0.0233 0.25 1.1 1 
7 15 0.0233 0.50 2.3 1 
Table 22: SDS-PAGE Analysis with Ellman’s Reagent 
*All reactions were performed in SPB 7.4. 
 
Sample Vi (µl) [PK] (mM) [HOCl] (mM) HOCl/PK Cys 
1 15 0.0233 0 0 
2 15 0.0233 0.050 0.23 
3 15 0.0233 0.10 0.45 
4 15 0.0233 0.25 1.1 
5 15 0.0233 0.50 2.3 
6 15 0.0233 0.75 3.4 
7 15 0.0233 1.0 4.5 
Table 2: Kinetic Assays with Hypochlorous Acid 
 
Sample Vi (µl) [PK] (mM) [HOCl] (mM) HOCl/PK Cys 25 mM IAF (µl) 
1 15 0.0233 0 0 1 
2 15 0.0233 0.050 0.23 1 
3 15 0.0233 0.10 0.45 1 
4 15 0.0233 0.25 1.1 1 
5 15 0.0233 0.50 2.3 1 
6 15 0.0233 0.75 3.4 1 
7 15 0.0233 1.0 4.5 1 
Table 23: SDS-PAGE Analysis with Hypochlorous Acid 
 
Sample V1 (µl) [PK]1 (mM) [MA]1 (mM) MA1/PK Cys V2 (µl) [PK]2 (mM) [MA]2 (mM) MA2/PK Cys 
1 15 0.0233 0 0 17 0.0207 0 0 
2 15 0.0233 0.50 HOCl 2.3 17 0.0207 0 0 
3 15 0.0233 0.50 HOCl 2.3 17 0.0207 4.0 DTT 20. 
4 15 0.0233 0.50 HOCl 2.3 17 0.0207 4.0 TCEP 20. 
5 15 0.0233 0.50 DTNB 2.3 17 0.0207 0 0 
6 15 0.0233 0.50 DTNB 2.3 17 0.0207 4.0 DTT 20. 
7 15 0.0233 0.50 DTNB 2.3 17 0.0207 4.0 TCEP 20. 
Table 24: Kinetic Analysis of HOCl/DTNB and DTT/TCEP Redox Variation 
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Sample V1 (µl) [PK]1 (mM) [MA]1 (mM) 
MA1/PK 
Cys V2 (µl) [PK]2 (mM) [MA]2 (mM) 
MA2/PK 
Cys 25 mM IAF (µl) 
1 15 0.0233 0 0 17 0.0207 0 0 1 
2 15 0.0233 0.50 HOCl 2.3 17 0.0207 0 0 1 
3 15 0.0233 0.50 HOCl 2.3 17 0.0207 4.0 DTT 20. 1 
4 15 0.0233 0.50 HOCl 2.3 17 0.0207 4.0 TCEP 20. 1 
5 15 0.0233 0.50 DTNB 2.3 17 0.0207 0 0 1 
6 15 0.0233 0.50 DTNB 2.3 17 0.0207 4.0 DTT 20. 1 
7 15 0.0233 0.50 DTNB 2.3 17 0.0207 4.0 TCEP 20. 1 
Table 25: SDS-PAGE Analysis of HOCl/DTNB and DTT/TCEP Redox Variation 
 
Sample V1 (µl)* [PK]1 (mM) [DTNB]** (mM) 
DTNB/PK 
Cys V2 (µl) [PK]2 (mM) [MA]2 (mM) 
MA2/PK 
Cys 
1 12 0.0146 0 0 17 0.0104 0 0 
2 12 0.0146 0.083 0.60 17 0.0104 0 0 
3 12 0.0146 0.083 0.60 17 0.0104 15 DTT 150 
4 12 0.0146 0.083 0.60 17 0.0104 15 TCEP 150 
Table 26: Kinetic Analysis of DTNB and DTT/TCEP Redox Variation 
*Because of the low [PK] used, a 1:5 dilution was used in place of a 1:100 dilution. 
**All reactions were performed in SPB 7.4. 
 
Sample V1 (µl)* [PK]1 (mM) [DTT] (mM)** 
DTT/PK 
Cys V2 (µl) [PK]2 (mM) [H2O2] (mM) 
H2O2/PK 
Cys Catalase (µl) 
1 12 0.0293 0 0 14 0.0251 0 0 3 
2 12 0.0293 0.83 3.0 14 0.0251 0 0 3 
3 12 0.0293 0.83 3.0 14 0.0251 7.1 30. 3 
Table 27: Kinetic Analysis of DTT and H2O2 Redox Variation 
*All reactions were performed in SPB 7.4. 
**Incubation time with DTT was 20 minutes. 
 
Sample V1 (µl)* [PK]1 (mM) [TCEP] (mM)** 
TCEP/PK 
Cys V2 (µl) [PK]2 (mM) [H2O2] (mM) 
H2O2/PK 
Cys Catalase (µl) 
1 12 0.0293 0 0 14 0.0251 0 0 3 
2 12 0.0293 0.83 3.0 14 0.0251 0 0 3 
3 12 0.0293 0.83 3.0 14 0.0251 7.1 30. 3 
Table 28: Kinetic Analysis of TCEP and H2O2 Redox Variation 
* Incubation time with TCEP was 20 minutes. 
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Appendix 3: SDS-PAGE Analysis 
 
SDS-PAGE analysis was used to visually estimate the extent of PK thiol modification. 
Given PK’s size (57 kDa), a 1.5 mm 7.5% separating gel and 1.5 mm 4% stacking gel 
combination was used. Separating gels were prepared by combining 10 ml dIH2O, 5 ml 1.5 mM 
Tris at pH 8.8, and 5 ml 30% acrylamide. The solution was degassed with swirling. To this 
solution was added 200 μl 10% SDS buffer in dIH2O, 100 μl (NH4)2S2O8 in dIH2O, and 10 μl 
N,N,N',N'-trimethylethylenediamine (TEMED). Separating gels were poured and coated with 
dIH2O-saturated butanol until the gels had polymerized, after which they were rinsed with dIH2O 
and dried. Stacking gels were prepared by mixing ~3.05 ml dIH2O with 1.25 ml 0.50 mM Tris at 
pH 6.8 and 670 μl 30% acrylamide. To the solution was added 50 μl each of 10% SDS and 
(NH4)2S2O8 and 6 μl TEMED. The stacking gels were quickly poured on top of the separating 
gels and polymerized around a 1.5 mm 9-well gel comb. 
Gels were run in 10% 10x Running Buffer at 90 V for 10-20 minutes, then at 110 V for 
40 minutes. They were imaged using the ChemiDoc XRS+ imaging system with Filter 1 on the 
Ethidium Bromide Nucleic Acid setting. Imaging was switched between Intense Band and Faint 
Band focusing based on which provided the clearest image and limited oversaturation. Gel 
images were then inverted in color in the Image Lab program, and light, dark, and gamma 
contrasts were altered to produce the best balance of contrast and image resolution. 
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